Fig. 1From: Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trialDiagram of phase 2a study. a Phase2a—group1. b Phase 2b—group 2Back to article page